Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BN.1.3.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBC.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Q.2 (Alpha)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BL.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
M.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.82 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
A.30NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.36.35NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.23.1 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.466.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CP.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FC.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BY.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.7.17NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.123 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.27NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1.71NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.12.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DN.1.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.51NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.17NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.28NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XRNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.350.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.254NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.39.1.1 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.418NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.9.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.40NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.122NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XAJNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.431NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.168NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AZ.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.97NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.36.18NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.32NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.59NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.67NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBQNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.6.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CR.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BV.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GA.4.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GS.7.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XWNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.1.10NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used